Udg Healthcare PLC Rating Reiterated by N+1 Singer (UDG)
Udg Healthcare PLC (LON:UDG)‘s stock had its “buy” rating reiterated by research analysts at N+1 Singer in a report released on Thursday. They currently have a GBX 410 ($6.90) target price on the stock. N+1 Singer’s price target points to a potential upside of 22.17% from the company’s current price.
Udg Healthcare PLC (LON:UDG) traded down 1.58% during mid-day trading on Thursday, hitting GBX 335.60. The stock had a trading volume of 282,125 shares. Udg Healthcare PLC has a 52-week low of GBX 292.90 and a 52-week high of GBX 381.747. The stock’s 50-day moving average is GBX 347.2 and its 200-day moving average is GBX 351.8. The company’s market cap is £810.2 million.
Other equities research analysts have also recently issued reports about the stock. Analysts at Davy Research reiterated an “outperform” rating on shares of Udg Healthcare PLC in a research note on Friday, August 1st. Separately, analysts at Goodbody Stockbrokers Ltd reiterated a “buy” rating on shares of Udg Healthcare PLC in a research note on Tuesday, July 8th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of GBX 380 ($6.39).
UDG Healthcare plc is an international provider of services to healthcare manufacturers and pharmaceutical retailers.
Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.